We're moving in a modified direction, I would say. The reason is simple. We invest among the largest amounts per capita in the world in R and D, and our results are not stellar. They're a long way from stellar.
Do we just continue with this system, or do we try to improve it to get better results? After all, this is a tax incentive program designed to get better R and D results, at the end of the day, so that it shows in the economy and helps create jobs.
We think, and Mr. Jenkins' panel was of some help to the government on this, that it would be a good idea to take some of the money and encourage young innovators, including the ones at McMaster University, which has a very good reputation for innovation in medical devices and all sorts of innovation.
There is risk to it. We'll see how well the venture capital scheme works. It will take several years to see how it takes hold. There are many reasons for a positive attitude toward this. We have some really good universities such as McMaster with great engineering programs, superb medical schools, and so on, and some very bright young people. We think they should get part of the action.